Find a Clinical Trial

Filter By:

Title	Investigator
A Multicenter Phase II Study of Sorafenib (BAY 43-9006) in Non-GIST Sarcomas [Protocol 05-081]	Maki, Robert, MD
A Phase III Trial of Oral Suberoylanilide Hydroxamic Acid (L-001079038) in Patients With Advanced Malignant Pleural Mesothelioma Previously Treated With Systemic Chemotherapy [Protocol 05-095]	Krug, Lee, MD
Phase I Study of S-1 in Combination with Oxaliplatin and Bevacizumab in Patients with Advanced Solid Tumors [Protocol 05-039]	Chung, Ki-Young, MD
2-[¹⁸F]-Deoxy-D-Glucose (FDG) and [¹⁸F] Dihydro-Testosterone PET Imaging in Patients with Progressive Prostate Cancer [Protocol 00-095]	Morris, Michael, MD
A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin's Lymphoma [Protocol 05-041]	Straus, David, MD
A Multicenter Treatment Protocol for Compassionate Use of Ipilimumab Monotherapy in Patients with Unresectable Stage III or Stage IV Melanoma [Protocol 07-156]	Wolchok, Jedd, MD, PhD
A Multicenter Trial Evaluating Computed Tomography and Serum CA-125 for the Management of Newly Diagnosed Ovarian Cancer [Protocol 01-048]	Chi, Dennis, MD
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma [Protocol 06-150]	Castro-Malaspina, Hugo, MD
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies [Protocol 06-066]	Barker, Juliet, MBBS
A Pharmacodynamic Assessment of the Effect of BIIB021 (CNF2024 or CF1983) in Patients with Gastrointestinal Stromal Tumors (GIST) Refractory to, Intolerant of, or Not Candidates for Imatinib and Sunitinib [Protocol 07-173]	Schwartz, Gary, MD
A Pharmacokinetic and Phase II Study of Sunitinib Malate in Recurrent Malignant Gliomas [Protocol 07-153]	Abrey, Lauren, MD
A Phase 1 Study of IPI-504 and Docetaxel in Patients with Advanced Solid Tumors [Protocol 07-154]	Riely, Gregory, MD, PhD
A Phase I Combination Trial of SGN-33 (Anti-huCD33 mAb; HuM195; Lintuzumab) and Lenalidomide (Revlimid^®) in Patients with Myelodysplastic Syndromes [Protocol 07-143]	Jurcic, Joseph, MD
A Phase I Dose-Escalation Study of BMS-641988 in Patients with Castration-Resistant Prostate Cancer [Protocol 06-030]	Scher, Howard, MD
A Phase I Study of 3F8 Antibody plus Granulocyte-Macrophage Colony-Stimulating Factor in High-Risk Neuroblastoma [Protocol 05-015]	Kushner, Brian, MD
A Phase I Study of AGS-PSCA in Patients with Advanced Prostate Cancer [Protocol 05-107]	Morris, Michael, MD
A Phase I Study of AZD4877 in Patients with Advanced Solid Tumors [Protocol 07-052]	Schwartz, Gary, MD
A Phase I Study of AZD7762 plus Irinotecan in Patients with Advanced Solid Malignancies [Protocol 07-057]	Tse, Archie, MD
A Phase I Study of Beta-Glucan and Rituximab in Children and Adolescents with Relapsed CD20-Positive Lymphoma or Leukemia or Post-Transplant Lymphoproliferative Disease [Protocol 03-095]	Modak, Shakeel, MD
A Phase I Study of CNF2024 Alone in Patients with HER2-Negative Advanced Breast Cancer or with Trastuzumab in Patients with HER2-Positive Advanced Breast Cancer [Protocol 07-123]	Modi, Shanu, MD
A Phase I Study of CNF2024 in Patients with B-Cell Chronic Lymphocytic Leukemia (CLL) [Protocol 06-048]	Lamanna, Nicole, MD
A Phase I Study of COX-2 Inhibition and Aromatase Activity in Breast Cancer [Protocol 03-027]	Port, Elisa, MD
A Phase I Study of CYT 107 in Recipients of HLA-Matched T Cell-Depleted Peripheral Blood Stem Cell or Bone Marrow Transplants [Protocol 07-127]	Van Den Brink, Marcel, MD, PhD
A Phase I Study of Clofarabine Plus Topotecan, Vinorelbine, Thiotepa, and Dexamethasone in Pediatric Patients with Relapsed or Refractory Acute Leukemia [Protocol 07-012]	Steinherz, Peter, MD
A Phase I Study of Flavopiridol Administered with Irinotecan (CPT-11) & Cisplatin in Patients with Advanced Solid Tumors [Protocol 02-043]	Shah, Manish, MD
A Phase I Study of Flavopiridol Given with Oxaliplatin, Fluorouracil, and Leucovorin in Patients with Advanced Solid Tumors [Protocol 03-146]	Schwartz, Gary, MD
A Phase I Study of Flavopiridol in Combination with Radiation in Locally Advanced, Non-Operable Pancreatic Cancer [Protocol 02-057]	Schwartz, Gary, MD
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia [Protocol 06-138]	Brentjens, Renier, MD, PhD
A Phase I Study of Hepatic Arterial Infusion and Intravenous Oxaliplatin and Irinotecan in Patients with Unresectable Hepatic Metastases from Colorectal Cancer [Protocol 00-011]	Kemeny, Nancy, MD
A Phase I Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone in Combination with Intravenous Oxaliplatin Plus 5-Fluorouracil & Leucovorin in Patients with Resectable Hepatic Metastases from Colorectal Cancer [Protocol 03-005]	Kemeny, Nancy, MD
A Phase I Study of Her2/neu DNA Immunization for Patients with Metastatic or High-Risk Breast Cancer [Protocol 04-101]	Gilewski, Teresa, MD
A Phase I Study of High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue, Lymph Nodes, or Bone [Protocol 06-101]	Zelefsky, Michael, MD
A Phase I Study of Intrathecal Radioimmunotherapy Using ¹³¹I-8H9 for Central Nervous System/Leptomeningeal Cancers [Protocol 03-133]	Kramer, Kim, MD
A Phase I Study of MDV3100 in Patients with Castration-Resistant Prostate Cancer [Protocol 07-045]	Scher, Howard, MD
A Phase I Study of MDX1411 in Patients with Advanced or Recurrent Clear Cell Renal Cell Carcinoma [Protocol 08-029]	Kroog, Glenn, MD
A Phase I Study of MK-4721 in Patients with Advanced Hormone-Refractory Prostate Cancer [Protocol 08-004]	Morris, Michael, MD
A Phase I Study of NY-ESO-1 Overlapping Peptides with or without Montanide Vaccination in Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Second or Third Remission [Protocol 07-152]	Sabbatini, Paul, MD
A Phase I Study of Oral Yeast Beta-glucan and Intravenous Anti-GD2 Monoclonal Antibody 3F8 Among Patients with Metastatic Neuroblastoma [Protocol 05-073]	Modak, Shakeel, MD
A Phase I Study of PDX (Pralatrexate) Supplemented with Vitamin B12 and Folic Acid in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer [Protocol 04-105]	Azzoli, Christopher, MD
A Phase I Study of PF-00477736 with Gemcitabine in Patients with Advanced Solid Malignancies [Protocol 07-017]	Tse, Archie, MD
A Phase I Study of PLX4032 in Patients with Metastatic Melanoma [Protocol 06-148]	Chapman, Paul, MD
A Phase I Study of Panitumumab in Children with Solid Tumors [Protocol 08-020]	Meyers, Paul, MD
A Phase I Study of Pralatrexate with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma [Protocol 07-146]	Horwitz, Steven, MD
A Phase I Study of R1507 in Children and Adolescents with Advanced Solid Tumors [Protocol 07-142]	Trippett, Tanya, MD
A Phase I Study of R7112 in People with Advanced Cancers (Except Leukemia) [Protocol 08-002]	Maki, Robert, MD
A Phase I Study of RAD001 and Sunitinib in Patients with Metastatic Renal Cell Carcinoma [Protocol 06-105]	Kroog, Glenn, MD
A Phase I Study of SGN-33 (Lintuzumab) in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome [Protocol 05-132]	Jurcic, Joseph, MD
A Phase I Study of Safingol and Cisplatin in Patients with Advanced Solid Tumors [Protocol 04-002]	Schwartz, Gary, MD
A Phase I Study of Trastuzumab-MCC-DM1 (PRO132365) in Patients with Metastatic Breast Cancer Who Have Previously Received Trastuzumab [Protocol 06-049]	Modi, Shanu, MD
A Phase I Study of Vorinostat (Suberoylanilide Hydroxamic Acid, or SAHA) in Combination with Temozolomide in Patients with Malignant Gliomas [Protocol 06-029]	Lassman, Andrew, MD
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation [Protocol 07-055]	O'Reilly, Richard, MD
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers [Protocol 06-155]	Aghajanian, Carol, MD
A Phase I Study of Weekly Low-Dose Cisplatin Plus Escalating Doses of Oral RAD001 (Everolimus) for Patients with Advanced Solid Tumors [Protocol 06-129]	Fury, Matthew, MD, PhD
A Phase I Study of XL281 in Patients with Advanced Solid Tumors [Protocol 07-020]	Schwartz, Gary, MD
A Phase I Study of XL765 in Combination with Temozolomide in Patients with Malignant Gliomas [Protocol 08-057]	Omuro, Antonio, MD
A Phase I Study of XL844 Alone and in Combination with Gemcitabine in Patients with Advanced Cancer [Protocol 07-081]	Tse, Archie, MD
A Phase I Study of Yttrium-90 Attached to Chimeric Monoclonal Antibody CG250 in Patients with Advanced Renal Cancer [Protocol 05-031]	Larson, Steven, MD
A Phase I Study of an Ethanol-Lock Strategy to Prevent Central Venous Catheter Infections Among Patients with High-Risk Neuroblastoma [Protocol 07-047]	Kayton, Mark, MD
A Phase I Study of the Monoclonal Antibody HGS-ETR2 (Lexatumumab) in Patients with Refractory Pediatric Solid Tumors [Protocol 07-071]	Merchant, Melinda, MD, PhD
A Phase I Study of the Safety and Pharmacokinetics of the Proteasome Inhibitor PR-171 in Patients with Hematological Cancers [Protocol 05-137]	Comenzo, Raymond, MD
A Phase I Trial of Doxorubicin and Flavopiridol in the Treatment of Metastatic Sarcoma [Protocol 04-075]	D'Adamo, David, MD
A Phase I Trial of Irinotecan, Radiation Therapy & Escalating Doses of Docetaxel with or without Cisplatin in Locally Advanced Esophageal Cancer [Protocol 02-061]	Ilson, David, MD
A Phase I Trial of PCK3145 in Patients with Asymptomatic, Castrate Metastatic Prostate Cancer [Protocol 05-019]	Slovin, Susan, MD, PhD
A Phase I Trial of Sequential Paclitaxel/Ifosfamide and Dose-Intensive Paclitaxel, Carboplatin, and Dose-Escalated Ifosfamide with Stem Cell Support in Cisplatin- Resistant Germ Cell Tumor Patients [Protocol 06-077]	Motzer, Robert, MD
A Phase I-II Study of Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Previously Treated Patients with Chronic Lymphocytic Leukemia and Other Low Grade B-Cell Cancers [Protocol 05-077]	Lamanna, Nicole, MD
A Phase I/II Clinical Trial of KOS-953 (17-AAG) and Trastuzumab (Herceptin^®) in Patients with Metastatic Breast Cancer [Protocol 04-114]	Hudis, Clifford, MD
A Phase I/II Study of Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis [Protocol 94-005]	Boulad, Farid, MD
A Phase I/II Study of BMS-753493 in Patients with Advanced Cancer [Protocol 08-032]	Konner, Jason, MD
A Phase I/II Study of Biweekly Capecitabine for the Treatment of Metastatic Breast Cancer [Protocol 05-030]	Traina, Tiffany, MD
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL) [Protocol 05-103]	Gerecitano, John, MD, PhD
A Phase I/II Study of Cisplatin, Etoposide, and Sunitinib for Untreated Advanced Small Cell Lung Cancer [Protocol 07-106]	Krug, Lee, MD
A Phase I/II Study of Clofarabine in Combination with Etoposide and Cyclophosphamide in Pediatric Patients with Refractory or Relapsed Acute Leukemia [Protocol 07-039]	Steinherz, Peter, MD
A Phase I/II Study of Clofarabine in Patients with Relapsed T-cell and NK-Cell Lymphomas [Protocol 06-065]	Horwitz, Steven, MD
A Phase I/II Study of Decitabine and All-Trans Retinoic Acid (Tretinoin) for Patients with Myelodysplastic Syndromes [Protocol 06-054]	Klimek, Virginia, MD
A Phase I/II Study of MDX-010 in Patients with Metastatic Hormone-Refractory Prostate Cancer [Protocol 05-067]	Slovin, Susan, MD, PhD
A Phase I/II Study of Obatoclax Mesylate (GX15-070MS) Plus Topotecan in Patients with Relapsed Small Cell Lung Carcinoma [Protocol 07-082]	Krug, Lee, MD
A Phase I/II Study of SB-743921 in Patients with Non-Hodgkin's Lymphoma [Protocol 07-083]	Gerecitano, John, MD, PhD
A Phase I/II Study of Temsirolimus (CCI-779) in Children with Relapsed or Refractory Solid Tumors (Part 2) [Protocol 07-060]	Dunkel, Ira, MD
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders [Protocol 95-024]	O'Reilly, Richard, MD
A Phase I/II Study to Assess AZD1152 in Patients with Acute Myeloid Leukemia [Protocol 08-014]	Berman, Ellin, MD
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies [Protocol 06-125]	Boulad, Farid, MD
A Phase I/II Trial of Fixed Doses of Daily Gefitinib with Escalating Doses of Daily RAD001 in Advanced Non-Small Cell Lung Cancer [Protocol 04-033]	Miller, Vincent, MD
A Phase I/II Trial of PTC299 in Patients with HIV-Related Kaposi's Sarcoma [Protocol 08-064]	Krown, Susan, MD
A Phase I/II Trial of Samarium (Sm-153) Lexidronam Combined with Docetaxel for Patients with Androgen-Independent Prostate Cancer [Protocol 05-014]	Morris, Michael, MD
A Phase I/II Trial of Vorinostat in Combination with Cyclophosphamide, Etoposide, Prednisone, and Rituximab for Elderly Patients with Relapsed Diffuse Large B-Cell Lymphoma [Protocol 08-045]	Straus, David, MD
A Phase I/IIA Study of Pralatrexate and Gemcitabine with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Lymphoma [Protocol 07-062]	Horwitz, Steven, MD
A Phase I/IIa Study Evaluating ABT-263 in Patients with Relapsed or Refractory Lymphoid Malignancies [Protocol 07-048]	Gerecitano, John, MD, PhD
A Phase IB Study Evaluating the Safety of BSI-201 in Combination with Chemotherapeutic Regimens in Patients with Advanced Solid Tumors [Protocol 08-048]	Bell-McGuinn, Katherine, MD, PhD
A Phase II Biomarker Pilot Trial of Fluvastatin Use in Women with Ductal Carcinoma in Situ or Stage I Breast Cancer [Protocol 06-041]	Port, Elisa, MD
A Phase II Clinical Trial of Bortezomib, Pegylated Liposomal Doxorubicin (DOXIL^®), and Dexamethasone Followed by Thalidomide and Dexamethasone with or without Bortezomib in Patients with High-Risk or Resistant Multiple Myeloma [Protocol 06-067]	Comenzo, Raymond, MD
A Phase II Clinical Trial of IMC-A12, Alone or with Cetuximab, in Patients with Metastatic Colorectal Cancer that Has Progressed Despite Anti-EGFR Therapy [Protocol 07-073]	Saltz, Leonard, MD
A Phase II Clinical and Translational Study of MK-0646 in Patients with Metastatic Neuroendocrine Tumors [Protocol 07-162]	Saltz, Leonard, MD
A Phase II Evaluation of Megestrol (Megace^®) for the Treatment of Endometrial Intraepithelial Neoplasia [Protocol 07-176]	Leitao, Mario, MD
A Phase II Evaluation of Trabectedin in the Treatment of Advanced, Persistent, or Recurrent Uterine Leiomyosarcomas [Protocol 07-134]	Hensley, Martee, MD
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers [Protocol 07-072]	Barker, Juliet, MBBS
A Phase II Pilot Trial of Hematopoietic Stem Cell Transplantation with Total Body Irradiation, Cyclophosphamide & Fludarabine to Treat Patients with Fanconi Anemia Lacking a Genotypically Identical Donor [Protocol 01-062]	Boulad, Farid, MD
A Phase II Randomized Controlled Trial of Acupuncture for Reduction of Post-Colectomy Ileus [Protocol 06-145]	Deng, Gary, MD, PhD
A Phase II Study Assessing Adjuvant Treatment of High-Risk Uterine Leiomyosarcoma with Gemcitabine/Docetaxel, Followed by Doxorubicin [Protocol 05-128]	Hensley, Martee, MD
A Phase II Study Comparing Two Different Doses of Biweekly Cetuximab for Platinum-Refractory Cancers of the Head and Neck [Protocol 08-039]	Fury, Matthew, MD, PhD
A Phase II Study Comparing Two Different Doses of Daily AZD2281 Versus Monthly Liposomal Doxorubicin in Patients with Advanced BRCA1- or BRCA2-Associated Ovarian Cancer That Has Progressed After Platinum-Based Chemotherapy [Protocol 08-054]	Bell-McGuinn, Katherine, MD, PhD
A Phase II Study Comparing Two Doses of Estradiol for the Treatment of Hormone Receptor-Positive Metastatic Breast Cancer [Protocol 06-132]	Dickler, Maura, MD
A Phase II Study of AZD0530 for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Protocol 06-074]	Pfister, David, MD
A Phase II Study of AZD0530 in Hormone Receptor-Negative Metastatic Breast Cancer or Unresectable Locally Advanced Breast Cancer [Protocol 07-112]	Hudis, Clifford, MD
A Phase II Study of All-Trans Retinoic Acid and Arsenic Trioxide for Previously Untreated Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy [Protocol 07-108]	Jurcic, Joseph, MD
A Phase II Study of Anti-GD2 Antibody 3F8 and GM-CSF for High-Risk Neuroblastoma [Protocol 03-077]	Kushner, Brian, MD
A Phase II Study of Apixaban for the Prevention of Blood Clots in Patients Undergoing Treatment for Advanced Cancer [Protocol 07-089]	Pietanza, Maria, MD
A Phase II Study of BIBW 2992 in Non-Small Cell Lung Cancer Patients with EGFR-Activating Mutations [Protocol 07-180]	Miller, Vincent, MD
A Phase II Study of BMS-663513 as Second-Line Monotherapy in Patients with Previously Treated Unresectable Stage III or Stage IV Melanoma [Protocol 08-027]	Wolchok, Jedd, MD, PhD
A Phase II Study of BSI-201 in Patients with BRCA1- or BRCA2-Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Protocol 08-044]	Bell-McGuinn, Katherine, MD, PhD
A Phase II Study of Bendamustine HCl in Relapsed and Primary Refractory Hodgkin's Lymphoma [Protocol 08-041]	Moskowitz, Craig, MD
A Phase II Study of Bicalutamide for the Treatment of Androgen Receptor-Positive, Estrogen and Progesterone Receptor-Negative Metastatic Breast Cancer [Protocol 07-022]	Hudis, Clifford, MD
A Phase II Study of Carboplatin and Gemcitabine with or without Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Protocol 07-078]	Aghajanian, Carol, MD
A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy or Intensity-Modulated Radiation Therapy Plus Bevacizumab for Locally or Regionally Advanced Nasopharyngeal Cancer [Protocol 07-030]	Lee, Nancy, MD
A Phase II Study of Conformal Radiotherapy in Patients with Low-Grade Gliomas [Protocol 07-049]	Dunkel, Ira, MD
A Phase II Study of Docetaxel, Cisplatin, and Fluorouracil with Bevacizumab in Patients with Unresectable or Metastatic Gastroesophageal Adenocarcinoma [Protocol 06-096]	Jhawer, Minaxi, MD
A Phase II Study of Dose-Escalated Rituximab and ICE for Patients with Primary Refractory and Poor-Risk Relapsed Aggressive B-cell Non-Hodgkin's Lymphoma Undergoing Second-Line Therapy Prior to Stem Cell Transplantation [Protocol 03-075]	Moskowitz, Craig, MD
A Phase II Study of E7389 in Recurrent Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer [Protocol 06-027]	Hensley, Martee, MD
A Phase II Study of Epirubicin, Cisplatin, Fluorouracil-Cetuximab, Irinotecan, Cisplatin-Cetuximab, or Folinic acid, Fluorouracil, Oxaliplatin-Cetuximab in Patients with Metastatic Esophageal and Gastroesophageal Junction Cancers [Protocol 07-145]	Jhawer, Minaxi, MD
A Phase II Study of Erlotinib (Tarceva^®) With or Without Carboplatin/Paclitaxel in Patients with Untreated Lung Adenocarcinoma Who Never Smoked or Were Former Light Smokers [Protocol 05-127]	Miller, Vincent, MD
A Phase II Study of Erlotinib and Chemotherapy for Operable Stage IB-IIIA Non-Small Cell Lung Cancer Patients Who Are Nonsmokers or Light Smokers [Protocol 07-103]	Rizvi, Naiyer, MD
A Phase II Study of Ertumaxomab in Patients with HER-2-Positive Metastatic Breast Cancer Progressing after Trastuzumab Treatment [Protocol 07-155]	Modi, Shanu, MD
A Phase II Study of GM-CSF (Sargramostim) and Rituximab Following Autologous Transplantation for Relapsed Follicular Lymphoma [Protocol 07-085]	Moskowitz, Craig, MD
A Phase II Study of Hepatic Arterial Infusion with Floxuridine and Dexamethasone in Combination with Intravenous Bevacizumab in Patients with Unresectable Primary Liver Cancer [Protocol 06-114]	Jarnagin, William, MD
A Phase II Study of IMC-1121B with or without Dacarbazine in Patients with Metastatic Malignant Melanoma [Protocol 07-136]	Carvajal, Richard, MD
A Phase II Study of IMC-A12 in Hepatocellular Carcinoma [Protocol 08-015]	Abou-Alfa, Ghassan, MD
A Phase II Study of Imatinib in Patients with Inoperable Stage III or IV Melanoma with Alterations in the C-KIT Protein [Protocol 07-014]	Carvajal, Richard, MD
A Phase II Study of Intrathecal I¹³¹-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms [Protocol 05-122]	Kramer, Kim, MD
A Phase II Study of Ipilimumab (MDX-010) Extended-Treatment Monotherapy or Follow-up for Patients Previously Enrolled in Ipilimumab Protocols [Protocol 06-135]	Wolchok, Jedd, MD, PhD
A Phase II Study of KU-0059436 in Patients with Advanced BRCA1- or BRCA2-Associated Breast Cancer [Protocol 07-117]	Robson, Mark, MD
A Phase II Study of LY573636 as Second-line or Third-line Treatment in Patients with Unresectable or Metastatic Soft-Tissue Sarcoma [Protocol 07-177]	Keohan, Mary, MD
A Phase II Study of LY573636 in Patients with Platinum-Resistant Ovarian Cancer [Protocol 07-065]	Tew, William, MD
A Phase II Study of Lapatinib plus Bevacizumab in Women with Advanced or Metastatic ErbB2-Overexpressing Breast Cancer [Protocol 07-018]	Dickler, Maura, MD
A Phase II Study of Lenalidomide and Rituximab for Patients with Relapsed and/or Refractory CD20+ Multiple Myeloma [Protocol 07-070]	Cohen, Adam, MD
A Phase II Study of Massage for the Treatment of Pain in Cancer [Protocol 03-046]	Cassileth, Barrie, PhD
A Phase II Study of Melphalan with Stem Cell Transplant and Adjuvant Bortezomib and Dexamethasone for Recently Diagnosed Untreated Systemic Light-Chain Amyloidosis [Protocol 07-006]	Comenzo, Raymond, MD
A Phase II Study of Motexafin-Gadolinium and Involved Field Radiation Therapy for Intrinsic Pontine Glioma of Childhood [Protocol 07-140]	Dunkel, Ira, MD
A Phase II Study of Neoadjuvant Gemcitabine and Oxaliplatin in Patients with Potentially Resectable Previously Untreated Pancreatic Adenocarcinoma [Protocol 07-113]	O'Reilly, Eileen, MD
A Phase II Study of Paclitaxel (IV and IP), Cisplatin (IP), and Bevacizumab (IV) for the Initial Treatment of Optimal Stage II or III Ovarian, Primary Peritoneal, and Fallopian Tube Cancer [Protocol 06-064]	Konner, Jason, MD
A Phase II Study of Panobinostat (LBH589) in Patients with Metastatic Hormone-Refractory Prostate Cancer [Protocol 08-013]	Rathkopf, Dana, MD, PhD
A Phase II Study of Pemetrexed and Gemcitabine for Metastatic/Recurrent Head and Neck Cancer [Protocol 06-087]	Pfister, David, MD
A Phase II Study of Pemetrexed in Children with Recurrent Malignancies [Protocol 07-179]	Trippett, Tanya, MD
A Phase II Study of Pentostatin with Cyclophosphamide and Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia [Protocol 05-051]	Weiss, Mark, MD
A Phase II Study of Peri-transplant Palifermin followed by an Allogeneic T-Cell-Depleted Stem Cell Transplant in Patients with Advanced Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Evolved from MDS [Protocol 08-008]	Castro-Malaspina, Hugo, MD
A Phase II Study of Preoperative Lycopene Supplementation in Prostate Cancer Patients [Protocol 06-118]	Eastham, James, MD
A Phase II Study of R-CHOP and ⁹⁰Y-Ibritumomab Tiuxetan (Zevalin) for Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma [Protocol 02-090]	Hamlin, Paul, MD
A Phase II Study of Radiotherapy (IMRT) and Cisplatin Plus Bevacizumab for Patients with Locally Advanced Head and Neck Cancer [Protocol 06-130]	Pfister, David, MD
A Phase II Study of Rituximab and Temozolomide in Recurrent Primary CNS Lymphoma [Protocol 05-119]	Abrey, Lauren, MD
A Phase II Study of Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-Dose Chemotherapy with Autologous Stem Cell Rescue in Newly Diagnosed Primary CNS Lymphoma [Protocol 04-129]	Abrey, Lauren, MD
A Phase II Study of Romidepsin in Progressive or Relapsed Peripheral T-Cell Lymphoma Following Prior Systemic Therapy [Protocol 07-095]	Horwitz, Steven, MD
A Phase II Study of SNS-595 in Patients with Platinum-Resistant Ovarian Cancer [Protocol 07-031]	Tew, William, MD
A Phase II Study of Salirasib for the Treatment of Advanced Non-Small Cell Lung Cancer [Protocol 07-110]	Riely, Gregory, MD, PhD
A Phase II Study of Sho-saiko-to in Patients with Chronic Hepatitis C Who Cannot Use Interferon [Protocol 02-073]	Deng, Gary, MD, PhD
A Phase II Study of Sorafenib (BAY 43-9006) for Patients with Imatinib-Resistant Malignant Gastrointestinal Stromal Tumor (GIST) [Protocol 06-028]	D'Adamo, David, MD
A Phase II Study of Sunitinib (Sutent^®) in Non-GIST Sarcomas [Protocol 07-054]	Keohan, Mary, MD
A Phase II Study of Sunitinib (Sutent^®) in Patients with Non-Small Cell Lung Cancer that Has Spread to the Brain [Protocol 07-010]	Abrey, Lauren, MD
A Phase II Study of Sunitinib (Sutent^®) in Patients with Renal Cell Carcinoma or Melanoma that Has Spread to the Brain [Protocol 07-009]	Abrey, Lauren, MD
A Phase II Study of Sunitinib in Metastatic Transitional Cell Carcinoma of the Urothelium [Protocol 06-081]	Bajorin, Dean, MD
A Phase II Study of Sunitinib in Patients with Refractory or Relapsed Germ Cell Tumors [Protocol 07-004]	Motzer, Robert, MD
A Phase II Study of XL647 in Subjects with Non Small-Cell Lung Cancer [Protocol 06-099]	Rizvi, Naiyer, MD
A Phase II Study of XL880 in Patients with Poorly Differentiated Metastatic Gastric Cancer [Protocol 07-138]	Jhawer, Minaxi, MD
A Phase II Study to Evaluate CT-322 (Angiocept^TM) Monotherapy and Combination Therapy with Irinotecan in Patients with Recurrent Glioblastoma Multiforme [Protocol 07-139]	Abrey, Lauren, MD
A Phase II Trial Comparing Three Different Treatment Schedules of ABI-007 in Combination with Bevacizumab in Women with Metastatic Breast Cancer [Protocol 06-025]	Seidman, Andrew, MD
A Phase II Trial of Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants after a Myeloablative Preparative Regimen for Adult Patients with Lymphohematopoietic Disorders [Protocol 01-070]	Jakubowski, Ann, MD, PhD
A Phase II Trial of Cetuximab plus Cisplatin and Irinotecan in Patients with Irinotecan- and Cisplatin-Refractory Metastatic Esophageal and Gastric Cancer [Protocol 06-095]	Ilson, David, MD
A Phase II Trial of Continuous Low-Dose Temozolomide for Patients with Recurrent Malignant Glioma [Protocol 07-064]	Abrey, Lauren, MD
A Phase II Trial of Dasatinib in Patients with Lung Adenocarcinoma with Acquired Resistance to Erlotinib or Gefitinib [Protocol 06-143]	Miller, Vincent, MD
A Phase II Trial of Doxorubicin, Rituximab, Cyclophosphamide, Vincristine, and Prednisone (DR-COP) in Patients with Newly Diagnosed AIDS-Associated B-Cell Non-Hodgkin's Lymphoma [Protocol 07-084]	Noy, Ariela, MD
A Phase II Trial of GW786034 (Pazopanib) in Subjects with Recurrent Glioblastoma [Protocol 07-097]	Abrey, Lauren, MD
A Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy-naïve Patients with Advanced/Metastatic Urothelial Carcinoma [Protocol 06-006]	Bajorin, Dean, MD
A Phase II Trial of HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia Following Allogeneic Hematopoietic Stem Cell Transplant [Protocol 07-035]	Hsu, Katharine, MD, PhD
A Phase II Trial of Intensive Chemotherapy & Autotransplantation in Patients with Newly Diagnosed Anaplastic Oligodendroglioma [Protocol 02-089]	Abrey, Lauren, MD
A Phase II Trial of Intravenous Myeloablative Chemotherapy Followed by an Allogeneic Hematopoietic Stem Cell Transplant from a Matched Relative to Treat High-Risk Ewing's Sarcoma Family Tumors [Protocol 05-059]	Prockop, Susan, MD
A Phase II Trial of Irinotecan plus Carboplatin, and Irinotecan Maintenance Therapy Integrated into the Upfront Therapy of Newly Diagnosed Patients with Intermediate- and High-Risk Rhabdomyosarcoma [Protocol 03-099]	Wexler, Leonard, MD
A Phase II Trial of Irinotecan, Cisplatin, Bevacizumab, and Concurrent Radiotherapy in Locally Advanced Esophageal Adenocarcinoma [Protocol 06-013]	Ilson, David, MD
A Phase II Trial of Liposomal Doxorubicin (Doxil^®) Followed by Bexarotene (Targretin^®) in Advanced Cutaneous T-Cell Lymphoma [Protocol 05-098]	Straus, David, MD
A Phase II Trial of Patupilone in Patients with Brain Metastases from Breast Cancer [Protocol 07-036]	Seidman, Andrew, MD
A Phase II Trial of Perifosine in Patients with Chemo-Insensitive Sarcomas [Protocol 07-104]	Maki, Robert, MD
A Phase II Trial of R1507 for People with Recurrent Sarcoma [Protocol 07-166]	Maki, Robert, MD
A Phase II Trial of Risk-Adapted High-Dose Chemoradiotherapy and Autologous Stem Cell Transplantation for Patients with Relapsed and Primary Refractory Hodgkin's Lymphoma [Protocol 04-047]	Moskowitz, Craig, MD
A Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases [Protocol 04-061]	Beal, Kathryn, MD
A Phase II Trial of Sunitinib (Sutent^®) in Patients with Recurrent or Inoperable Meningioma [Protocol 07-135]	Abrey, Lauren, MD
A Phase II Trial of T Cell Depleted Peripheral Blood Stem Cell Transplantation to Treat Patients with AML in First or Second Complete Remission [Protocol 06-005]	O'Reilly, Richard, MD
A Phase II Trial of Temozolomide and Radiotherapy Followed by Temozolomide and Maintenance Cis-retinoic Acid for Patients with Newly Diagnosed Gliomas [Protocol 05-079]	Abrey, Lauren, MD
A Phase II Trial to Correlate Response to Gefitinib with Mutations in the EGFR Gene in Patients with Non-Small Cell Lung Cancer [Protocol 04-071]	Rizvi, Naiyer, MD
A Phase II/III Study of Abagovomab Maintenance Therapy in Patients with Epithelial Ovarian Cancer after Complete Response to First-line Chemotherapy [Protocol 06-144]	Sabbatini, Paul, MD
A Phase IIB Study of Low-Dose Cytarabine Alone and with Lintuzumab in Patients Age 60 and Older with Previously Untreated AML [Protocol 08-010]	Jurcic, Joseph, MD
A Phase III Study Assessing Carboplatin and/or Isotretinoin plus Radiation in Patients with Supratentorial Primitive Neuroectodermal Tumor or High-Risk Medulloblastoma [Protocol 07-174]	Gilheeney, Stephen, MD
A Phase III Study Comparing Ibritumomab Tiuxetan (Zevalin^®) with Observation in Patients with Diffuse Large B-Cell Lymphoma in Complete Remission after Initial CHOP-R Therapy [Protocol 07-061]	Hamlin, Paul, MD
A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low-Risk Hodgkin's Lymphoma [Protocol 07-008]	Trippett, Tanya, MD
A Phase III Study of Active Surveillance Therapy versus Radical Treatment in Patients Diagnosed with Favorable Prostate Cancer (START) [Protocol 08-022]	Eastham, James, MD
A Phase III Study of Adjuvant Sunitinib versus Placebo in Patients with High-Risk Renal Cell Carcinoma [Protocol 07-086]	Motzer, Robert, MD
A Phase III Study of Androgen Deprivation with Leuprolide with or without Docetaxel for Clinically Asymptomatic Prostate Cancer Patients with a Rising PSA Following Surgery [Protocol 07-101]	Morris, Michael, MD
A Phase III Study of Cisplatin and Radiation Therapy with and without Tirapazamine in Stage IB2-IVA Cervical Carcinoma Limited to the Pelvis [Protocol 07-128]	Leitao, Mario, MD
A Phase III Study of Conventional Whole Breast Irradiation Versus Partial Breast Irradiation for Women with Early-Stage Breast Cancer [Protocol 05-068]	McCormick, Beryl, MD
A Phase III Study of Early Versus Standard Zoledronic Acid to Prevent Bone Problems in Men with Prostate Cancer that Has Spread to the Bone [Protocol 06-091]	Morris, Michael, MD
A Phase III Study of Fulvestrant with or without Lapatinib (Tykerb^®) for Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer [Protocol 07-122]	Lake, Diana, MD
A Phase III Study of Imatinib Versus Nilotinib in Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia in Chronic Phase [Protocol 08-033]	Heaney, Mark, MD, PhD
A Phase III Study of Intensive Induction Chemotherapy with or without Methotrexate Followed by Consolidation Therapy with Stem Cell Rescue in Young Children Newly Diagnosed with Supratentorial PNET or High-Risk Medulloblastoma [Protocol 07-170]	Gilheeney, Stephen, MD
A Phase III Study of Maintenance Therapy with CC-5013 or Placebo After Autologous Stem Cell Transplantation for Multiple Myeloma [Protocol 05-080]	Hassoun, Hani, MD
A Phase III Study of Mycobacterial Cell Wall-DNA Complex for Patients with Superficial Bladder Cancer at High Risk of Progression Who Are Refractory to Bacillus Calmette-Guerin [Protocol 07-016]	Herr, Harry, MD
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer [Protocol 07-041]	Eastham, James, MD
A Phase III Study of Sunitinib Alone or in Combination with Interferon Alfa-2B as First-Line Therapy for Metastatic Renal Cell Cancer (Renal EFFECT Trial) [Protocol 05-124]	Motzer, Robert, MD
A Phase III Study of the Continued Safety and Effectiveness of Zometa^® in Patients with Bone Metastases from Breast Cancer [Protocol 06-119]	Fornier, Monica, MD
A Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-Intensive Temozolomide in Patients with Newly Diagnosed Glioblastoma [Protocol 07-075]	Lassman, Andrew, MD
A Phase III Trial Comparing Docetaxel and Prednisone with and without Bevacizumab in Men with Hormone-Refractory Prostate Cancer [Protocol 05-078]	Morris, Michael, MD
A Phase III Trial Evaluating Ovarian Function Suppression and Exemestane in Premenopausal Women with Early Endocrine-Responsive Breast Cancer [Protocol 04-104]	Dickler, Maura, MD
A Phase III Trial of Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue [Protocol 04-081]	Deng, Gary, MD, PhD
A Phase III Trial of Adjuvant Chemoradiation after Surgery for Gastric or Gastroesophageal Cancer [Protocol 06-055]	Shah, Manish, MD
A Phase III Trial of Carboplatin and Paclitaxel With and Without Bevacizumab to Treat Newly Diagnosed Ovarian and Primary Peritoneal Cancer [Protocol 05-138]	Leitao, Mario, MD
A Phase III Trial of Cyclophosphamide and Doxorubicin versus Paclitaxel as Adjuvant Therapy for Women with Node-Negative Breast Cancer [Protocol 04-042]	Lake, Diana, MD
A Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with or without Bevacizumab in Patients with Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer [Protocol 08-035]	Dang, Chau, MD
A Phase III Trial of Doxorubicin/Cisplatin/Paclitaxel/G-CSF Versus Carboplatin/Paclitaxel in Patients with Stage III/IV or Recurrent Endometrial Cancer [Protocol 04-013]	Leitao, Mario, MD
A Phase III Trial of Zoledronic Acid with and without Thalidomide in Patients with Early-Stage Multiple Myeloma [Protocol 06-015]	Hassoun, Hani, MD
A Phase IIIb Trial Comparing Bevacizumab Therapy with/without Erlotinib After Completion of Chemotherapy with Bevacizumab for the First-Line Treatment of Locally Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer [Protocol 06-098]	Miller, Vincent, MD
A Phase IIb Study of Gemcitabine with or without Sorafenib in Women with Locally Advanced or Metastatic Breast Cancer that has Progressed During or After Bevacizumab Therapy [Protocol 07-131]	Hudis, Clifford, MD
A Phase Ia/Ib Study of a DNA Vaccine in Patients with Stage IIB-IV Malignant Melanoma [Protocol 07-003]	Wolchok, Jedd, MD, PhD
A Phase Ib Study of Panobinostat (LBH589) with Docetaxel and Prednisone in Patients with Hormone-Refractory Prostate Cancer [Protocol 07-163]	Rathkopf, Dana, MD, PhD
A Phase Ib Study of the Anti-VEGF Agent PTC299 in Patients with Advanced Cancer [Protocol 08-043]	Schwartz, Gary, MD
A Phase Ib/II Study of AMG 655 plus Modified FOLFOX6 and Bevacizumab for the Initial Treatment of Patients with Metastatic Colorectal Cancer [Protocol 07-161]	Saltz, Leonard, MD
A Pilot Phase II Study of Targeted Radiotherapy with ¹³¹I-MIBG and Arsenic Trioxide in Patients with Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors [Protocol 04-148]	Modak, Shakeel, MD
A Pilot Study of Combined Immunochemotherapy Followed by Reduced Dose Radiotherapy for Patients with Newly Diagnosed Primary Central Nervous System Lymphoma [Protocol 01-146]	Abrey, Lauren, MD
A Pilot Study of Docetaxel plus Vinorelbine as Adjuvant Chemotherapy for Patients with Resected Non-Small Cell Lung Cancer [Protocol 07-178]	Azzoli, Christopher, MD
A Pilot Study of Dose-Dense Adjuvant CMF (Cyclophosphamide, Methotrexate, and Fluorouracil) at 14-Day Intervals for Women with Early Breast Cancer [Protocol 07-133]	Drullinsky, Pamela, MD
A Pilot Study of High Dose-Rate Prostate Brachytherapy as Salvage Therapy for Locally Recurrent Prostate Cancer Previously Treated with External Beam Radiotherapy [Protocol 06-122]	Yamada, Yoshiya, MD
A Pilot Study of High-Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer [Protocol 07-120]	Yamada, Yoshiya, MD
A Pilot Study of Neoadjuvant Chemotherapy with Selective Use of Radiation for Locally Advanced Rectal Cancer [Protocol 07-021]	Saltz, Leonard, MD
A Pilot Study of PD 0332991 in Patients with Previously Treated Mantle Cell Lymphoma [Protocol 07-172]	Noy, Ariela, MD
A Pilot Study of Topical Imiquimod Therapy for the Treatment of Recurrent Extramammary Paget's Disease [Protocol 07-029]	Chi, Dennis, MD
A Pilot Trial Assessing the Safety and Immunogenicity of the GI-4000 Vaccine as Consolidation Therapy after Curative Treatment for Stage I-III Non-Small Cell Lung Cancers with K-ras Mutations [Protocol 07-149]	Azzoli, Christopher, MD
A Pilot Trial of a WT-1 Analog Peptide Vaccine in Patients with Thoracic and Myeloid Neoplasms [Protocol 06-085]	Krug, Lee, MD
A Pilot Trial to Assess the Feasibility and Safety of G-CSF Mobilization of Hematopoietic Stem Cells in Patients with Beta-thalassemia Major [Protocol 08-030]	Boulad, Farid, MD
A Prospective International Multicenter Phase III Clinical Trial of PI-88 as Adjuvant Treatment for Hepatocellular Carcinoma [Protocol 08-012]	Abou-Alfa, Ghassan, MD
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration [Protocol 05-001]	Chi, Dennis, MD
A Prospective, Longitudinal Study to Examine Time-Dependent Neurocognitive Changes in Patients with Breast Cancer Receiving Adjuvant Chemotherapy [Protocol 07-130]	Ahles, Tim, PhD
A Prospective, Multicenter Trial of NovoTTF-100A Compared to Best Standard of Care in Patients with Progressive or Recurrent Glioblastoma Multiforme [Protocol 06-093]	Gutin, Philip, MD
A Randomized Controlled Trial of Family-Focused Grief Therapy in Palliative Care and Bereavement [Protocol 05-120]	Kissane, David, MD
A Randomized Phase II Study of Hepatic Arterial Infusion in Combination with Intravenous Chemotherapy, with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer [Protocol 04-086]	Kemeny, Nancy, MD
A Randomized Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) Treatment versus Conventional DCF with Growth Factor Support in Patients with Unresectable or Metastatic Gastric and Gastroesophageal Junction Cancer [Protocol 06-103]	Shah, Manish, MD
A Study Assessing the Use of AlloDerm in Two-Stage, Tissue Expander/Implant Breast Reconstruction [Protocol 08-024]	Disa, Joseph, MD
A Study Comparing Beads with Doxorubicin-Eluting Beads for Arterial Embolization of Hepatocellular Carcinoma [Protocol 07-099]	Brown, Karen, MD
A Study Evaluating the Effectiveness of Leuprolide for Enhancing Immune Function After Autologous Stem Cell Transplantation [Protocol 07-046]	Cohen, Adam, MD
A Study of Brivanib in Patients with Advanced Tumors [Protocol 08-061]	Schwartz, Gary, MD
A Study of Group Psychotherapy Interventions for People with Cancer [Protocol 07-094]	Breitbart, William, MD
A Study of Positron Emission Tomography (PET) Scanning for the Pre-Operative Evaluation of Patients with Primary and Recurrent Breast Carcinoma [Protocol 01-134]	Port, Elisa, MD
A Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin's Lymphoma [Protocol 07-147]	Perales, Miguel-Angel, MD
A Study of Temsirolimus and Sorafenib as Second-Line Therapy in Patients with Advanced Renal Cell Carcinoma that Has Grown Despite First-Line Sunitinib Therapy [Protocol 07-124]	Motzer, Robert, MD
A Study to Evaluate the Safety and Efficacy of AMG 531 in Thrombocytopenic Patients with Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Protocol 06-115]	Klimek, Virginia, MD
A Survey of Penile Injection Anxiety [Protocol 07-001]	Nelson, Christian, PhD
A Survey of Sleep Problems in Survivors of Early-Stage Breast Cancer [Protocol 06-071]	Passik, Steven, PhD
ALTE03N1: Key Adverse Events Following Childhood Cancer [Protocol 05-070]	Sklar, Charles, MD
Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Leukemia Following Total Body Irradiation and Stem Cell Transplant [Protocol 07-092]	Oeffinger, Kevin, MD
Adherence to Comprehensive, Multi-Organ Screening Recommendations in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients [Protocol 04-144]	Hurley, Karen, PhD
Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors [Protocol 04-122]	Correa, Denise, PhD
Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer [Protocol 08-017]	Dang, Chau, MD
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders [Protocol 00-069]	Offit, Kenneth, MD
Assessing Depression in a Geriatric Cancer Population [Protocol 06-100]	Nelson, Christian, PhD
Attitudes Towards Prophylactic Colectomy in HNPCC Patients [Protocol 04-127]	Hurley, Karen, PhD
BRCA1 Haploinsufficiency and Gene Expression [Protocol 04-045]	King, Tari, MD
Biaxin (Clarithromycin)-Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma [Protocol 07-038]	Portlock, Carol, MD
Biomarkers of Molecular Risk in Smokers [Protocol 04-141]	Boyle, Jay, MD
Breast MRI as a Preoperative Tool for DCIS [Protocol 06-124]	Van Zee, Kimberly, MD
Chemotherapy Decisions and Outcomes in Women Age 65 or Older with Operable, Newly Diagnosed Breast Cancer [Protocol 04-030]	Lake, Diana, MD
Chemotherapy-Induced Changes in Cognition and DNA in Breast Cancer Survivors [Protocol 07-090]	Ahles, Tim, PhD
Clinical Outcomes in Hereditary Cancer [Protocol 06-004]	Robson, Mark, MD
Clinical Significance of Germline BRCA Mutations [Protocol 96-051]	Offit, Kenneth, MD
Clinical Study of McGhan Corporation Style 410 Silicone-Filled Breast Implants [Protocol 06-024]	Disa, Joseph, MD
Cognitive Behavioral Intervention for BMT/SCT Survivors [Protocol 04-139]	DuHamel, Katherine, PhD
Collection of Saliva Samples for Genetic Epidemiology Studies of Cancer and Aging [Protocol 06-102]	Offit, Kenneth, MD
Combination of Targeted I¹³¹-3F8-Mediated Radioimmunotherapy and Bevacizumab in Patients with Relapsed or Refractory Neuroblastoma: A Phase I Study [Protocol 06-072]	Modak, Shakeel, MD
Contrast-Enhanced Breast MRI Evaluation of Patients Undergoing Neoadjuvant Treatment for Locally Advanced Breast Cancer [Protocol 03-019]	Morris, Elizabeth, MD
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance [Protocol 06-110]	Carter, Jeanne, PhD
Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy [Protocol 06-014]	Barker, Juliet, MBBS
Cytologic Analysis of Ductal Lavage Specimens [Protocol 01-101]	Montgomery, Leslie, MD
Decision-Making Regarding Prophylactic Mastectomy & Oophorectomy in Women Seeking Genetic Testing for Inherited BRCA1 and BRCA2 Mutations [Protocol 03-001]	Hurley, Karen, PhD
Depression, Cytokines, and Pancreatic Cancer [Protocol 05-117]	Breitbart, William, MD
Development and Validation of a New Patient-Reported Outcome Instrument on the Impact of Altered Facial Appearance Following Oncologic Head and Neck Resection and Reconstruction [Protocol 07-098]	Pusic, Andrea, MD, MHS
Early Onset and Familial Gastric Cancer Registry [Protocol 05-118]	Shah, Manish, MD
Effect of Commonly Used Anesthesia Drugs on Memory [Protocol 04-087]	Pryor, Kane, MD
Effect of Imatinib on Bone Metabolism, Lipid Metabolism, and Thyroid Function in Patients with Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors [Protocol 06-142]	Berman, Ellin, MD
Estrogen, Diet, Genetics & Endometrial Cancer [Protocol 01-119]	Olson, Sara, PhD
Evaluating the Response to Pre-operative C